Effectiveness of a Nonpneumatic Active Compression Device in Older Adults with Breast Cancer-Related Lymphedema: A Subanalysis of a Randomized Crossover Trial
Lymphatic Research and Biology · 01.12.2023 · 21 (6) · 581-584
DOI: 10.1089/lrb.2022.0085 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Lymphatic Research and Biology, online erschienen am 22.12.2023. Verfasst von Stanley G Rockson und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Breast Cancer Lymphedema, Lymphedema. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Background
A recently completed clinical trial compared a novel nonpneumatic compression device (NPCD) with a traditional advanced pneumatic compression device (APCD) for the treatment of breast cancer-related lymphedema (BCRL); the study revealed that the NPCD produced superior clinical and quality-of-life (QOL) outcomes. In this subanalysis, we sought to examine these results within the subset of trial subjects aged ≥65 years.
Methods
A randomized crossover head-to-head trial was conducted to compare the NPCD with a commercially available APCD. Patients were randomly assigned to one or the other device for 28 days of use, followed by a 4-week washout period before a comparable 28-day utilization of the alternate device. Limb edema, adherence to daily device use, and QOL measures were collected at day 0 and 28 of each period.
Results
A total of 14 subjects were aged ≥65. During NPCD use, subjects experienced a mean decrease in limb edema of 100.3% ( p = 0.0082) as well as improvements in mean overall and subscale scores of the Lymphedema Quality of Life Questionnaire (LYMQOL). By comparison, during APCD use limb edema decreased by a mean of 2.9% ( p = 0.8899) with no significant changes in any LYMQOL scores. Mean adherence was significantly higher during NPCD use (96.6%) than during APCD use (58.3%, p < 0.0001).
Conclusions
The novel NPCD produced superior clinical and QOL outcomes in older subjects with BCRL. ClinicalTrials.gov ID: NCT04908254
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California, USA.
- Department of Plastic Surgery, The Ohio State University Medical Center, Columbus, Ohio, USA.
Zitieren
APA
Rockson, S. G., & Skoracki, R. (2023). Effectiveness of a Nonpneumatic Active Compression Device in Older Adults with Breast Cancer-Related Lymphedema: A Subanalysis of a Randomized Crossover Trial. Lymphatic Research and Biology, 21(6), 581-584. https://doi.org/10.1089/lrb.2022.0085
Vancouver
Rockson SG, Skoracki R. Effectiveness of a Nonpneumatic Active Compression Device in Older Adults with Breast Cancer-Related Lymphedema: A Subanalysis of a Randomized Crossover Trial. Lymphatic Research and Biology. 2023;21(6):581-584. doi:10.1089/lrb.2022.0085
BibTeX
@article{Rockson2023,
author = {Rockson, Stanley G and Skoracki, Roman},
title = {Effectiveness of a Nonpneumatic Active Compression Device in Older Adults with Breast Cancer-Related Lymphedema: A Subanalysis of a Randomized Crossover Trial},
journal = {Lymphatic Research and Biology},
year = {2023},
volume = {21},
number = {6},
pages = {581--584},
doi = {10.1089/lrb.2022.0085}
}
EUVIMED